Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
2 GLP-1 Market Reflects a Financialized Business Model: The financialized business models of Novo Nordiskand Eli Lilly illustrate their focus on sustaining long-term profitability over public health needs
launched a biosimilar of the popular anti-diabetic drug Liraglutide in India, marketing it as Lirafit after obtaining approval from the Drug Controller General of India (DCGI)
Slavin JL, Savarino V, Paredes-Diaz A, Fotopoulos G
cardiometabolic risk reduction
Ozempic has been widely used off-label to support weight loss due to its appetite-suppressing effects
US$ 25.01
US$ 26.54
US$ 24.66
US$ 22.67
US$ 28.42
